Skip to main content
. Author manuscript; available in PMC: 2014 May 28.
Published in final edited form as: Circulation. 2013 Apr 26;127(21):2075–2077. doi: 10.1161/CIRCULATIONAHA.113.003058

Figure 1.

Figure 1

Utilizing both mechanistic and unbiased miRNA studies to understand disease. Using global miRNA profiling of ventricles during development of severe hypertrophic cardiomyopathy and heart failure7, 13 with mechanistic observations from specific miRNAs5 and predicted targets, combinatorial approaches can be pursued that could yield increasingly relevant in vivo data. These approaches acknowledge that there is both increased and decreased miRNA expression in disease settings and these miRNAs may target a broad number of compensatory and non-compensatory pathways.